NCT00002329View on ClinicalTrials.gov

A Study of MDL 28,574A in HIV-Infected Patients

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

Not specified

Conditions
HIV Infections
Interventions
DRUG

Celgosivir hydrochloride

Trial Locations (1)

94109

Saint Francis Mem Hosp, San Francisco

Sponsors
All Listed Sponsors
lead

Hoechst Marion Roussel

INDUSTRY

NCT00002329 - A Study of MDL 28,574A in HIV-Infected Patients | Biotech Hunter | Biotech Hunter